Literature DB >> 16885468

Solution structure of the conserved hypothetical protein Rv2302 from Mycobacterium tuberculosis.

Garry W Buchko1, Chang-Yub Kim, Thomas C Terwilliger, Michael A Kennedy.   

Abstract

The Mycobacterium tuberculosis protein Rv2302 (80 residues; molecular mass of 8.6 kDa) has been characterized using nuclear magnetic resonance (NMR) and circular dichroism (CD) spectroscopy. While the biochemical function of Rv2302 is still unknown, recent microarray analyses show that Rv2302 is upregulated in response to starvation and overexpression of heat shock proteins and, consequently, may play a role in the biochemical processes associated with these events. Rv2302 is a monomer in solution as shown by size exclusion chromatography and NMR spectroscopy. CD spectroscopy suggests that Rv2302 partially unfolds upon heating and that this unfolding is reversible. Using NMR-based methods, the solution structure of Rv2302 was determined. The protein contains a five-strand, antiparallel beta-sheet core with one C-terminal alpha-helix (A61 to A75) nestled against its side. Hydrophobic interactions between residues in the alpha-helix and beta-strands 3 and 4 hold the alpha-helix near the beta-sheet core. The electrostatic potential on the solvent-accessible surface is primarily negative with the exception of a positive arginine pocket composed of residues R18, R70, and R74. Steady-state {(1)H}-(15)N heteronuclear nuclear Overhauser effects indicate that the protein's core is rigid on the picosecond timescale. The absence of amide cross-peaks for residues G13 to H19 in the (1)H-(15)N heteronuclear single quantum correlation spectrum suggests that this region, a loop between beta-strands 1 and 2, undergoes motion on the millisecond to microsecond timescale. Dali searches using the structure closest to the average structure do not identify any high similarities to any other known protein structure, suggesting that the structure of Rv2302 may represent a novel protein fold.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16885468      PMCID: PMC1540057          DOI: 10.1128/JB.00460-06

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  32 in total

1.  Influence of non-bonded parameters on the quality of NMR structures: a new force field for NMR structure calculation.

Authors:  J P Linge; M Nilges
Journal:  J Biomol NMR       Date:  1999-01       Impact factor: 2.835

2.  Overexpression of heat-shock proteins reduces survival of Mycobacterium tuberculosis in the chronic phase of infection.

Authors:  G R Stewart; V A Snewin; G Walzl; T Hussell; P Tormay; P O'Gaora; M Goyal; J Betts; I N Brown; D B Young
Journal:  Nat Med       Date:  2001-06       Impact factor: 53.440

Review 3.  Protein dynamics from NMR.

Authors:  R Ishima; D A Torchia
Journal:  Nat Struct Biol       Date:  2000-09

4.  MOLMOL: a program for display and analysis of macromolecular structures.

Authors:  R Koradi; M Billeter; K Wüthrich
Journal:  J Mol Graph       Date:  1996-02

5.  Solution-state NMR investigation of DNA binding interactions in Escherichia coli formamidopyrimidine-DNA glycosylase (Fpg): a dynamic description of the DNA/protein interface.

Authors:  Garry W Buchko; Kathleen McAteer; Susan S Wallace; Michael A Kennedy
Journal:  DNA Repair (Amst)       Date:  2005-03-02

6.  Spectroscopic studies of zinc(II)- and cobalt(II)-associated Escherichia coli formamidopyrimidine-DNA glycosylase: extended X-ray absorption fine structure evidence for a metal-binding domain.

Authors:  G W Buchko; N J Hess; V Bandaru; S S Wallace; M A Kennedy
Journal:  Biochemistry       Date:  2000-10-10       Impact factor: 3.162

7.  1H, 13C and 15N chemical shift referencing in biomolecular NMR.

Authors:  D S Wishart; C G Bigam; J Yao; F Abildgaard; H J Dyson; E Oldfield; J L Markley; B D Sykes
Journal:  J Biomol NMR       Date:  1995-09       Impact factor: 2.835

8.  Backbone 1H and 15N resonance assignments of the N-terminal SH3 domain of drk in folded and unfolded states using enhanced-sensitivity pulsed field gradient NMR techniques.

Authors:  O Zhang; L E Kay; J P Olivier; J D Forman-Kay
Journal:  J Biomol NMR       Date:  1994-11       Impact factor: 2.835

9.  The 13C chemical-shift index: a simple method for the identification of protein secondary structure using 13C chemical-shift data.

Authors:  D S Wishart; B D Sykes
Journal:  J Biomol NMR       Date:  1994-03       Impact factor: 2.835

10.  Backbone dynamics of Escherichia coli ribonuclease HI: correlations with structure and function in an active enzyme.

Authors:  A M Mandel; M Akke; A G Palmer
Journal:  J Mol Biol       Date:  1995-02-10       Impact factor: 5.469

View more
  5 in total

1.  Solution structure of Rv2377c-founding member of the MbtH-like protein family.

Authors:  Garry W Buchko; Chang-Yub Kim; Thomas C Terwilliger; Peter J Myler
Journal:  Tuberculosis (Edinb)       Date:  2010-07       Impact factor: 3.131

2.  Chemical shift assignments for Rv0577, a putative glyoxylase associated with virulence from Mycobacterium tuberculosis.

Authors:  Garry W Buchko; Heungbok Kim; Peter J Myler; Thomas C Terwilliger; Chang-Yub Kim
Journal:  Biomol NMR Assign       Date:  2011-07-15       Impact factor: 0.746

3.  Inaugural structure from the DUF3349 superfamily of proteins, Mycobacterium tuberculosis Rv0543c.

Authors:  Garry W Buchko; Isabelle Phan; Peter J Myler; Thomas C Terwilliger; Chang-Yub Kim
Journal:  Arch Biochem Biophys       Date:  2010-12-06       Impact factor: 4.013

4.  Botulinum Neurotoxin Serotype A Recognizes Its Protein Receptor SV2 by a Different Mechanism than Botulinum Neurotoxin B Synaptotagmin.

Authors:  Jasmin Weisemann; Daniel Stern; Stefan Mahrhold; Brigitte G Dorner; Andreas Rummel
Journal:  Toxins (Basel)       Date:  2016-05-17       Impact factor: 4.546

Review 5.  Solution NMR Studies of Mycobacterium tuberculosis Proteins for Antibiotic Target Discovery.

Authors:  Do-Hee Kim; Sung-Min Kang; Bong-Jin Lee
Journal:  Molecules       Date:  2017-08-31       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.